Kintor Pharmaceutical Ltd. has announced that it has entered into a subscription agreement on November 12, 2025, for the issuance of new shares under a general mandate. The agreement with the subscriber involves a private placement of shares, but the company notes that the subscription may or may not proceed to completion. Shareholders and potential investors are advised to exercise caution when dealing in the company's securities.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kintor Pharmaceutical Ltd. published the original content used to generate this news brief on November 12, 2025, and is solely responsible for the information contained therein.